Literature DB >> 23403420

Antimicrobial susceptibilities of clinical isolates of HACEK organisms.

Bryan Coburn1, Baldwin Toye, Prasad Rawte, Frances B Jamieson, David J Farrell, Samir N Patel.   

Abstract

The "HACEK" organisms are a group of fastidious Gram-negative bacteria that cause a variety of infections, including infective endocarditis. Antimicrobial susceptibility testing is not universally available, and therapy for these infections is often empirical. We report the antimicrobial susceptibilities of 70 clinical HACEK isolates to 18 antimicrobials. All isolates were susceptible to ceftriaxone and levofloxacin, indicating that these agents remain appropriate empirical choices for the treatment of infections with this group of organisms.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23403420      PMCID： PMC3623346          DOI： 10.1128/AAC.00111-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Antibiotic susceptibility of Kingella kingae isolates from respiratory carriers and patients with invasive infections.

Authors:  P Yagupsky; O Katz; N Peled
Journal:  J Antimicrob Chemother       Date:  2001-02       Impact factor: 5.790

2.  Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms.

Authors:  K C Kugler; D J Biedenbach; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1999-05       Impact factor: 2.803

3.  Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Ann F Bolger; Matthew E Levison; Patricia Ferrieri; Michael A Gerber; Lloyd Y Tani; Michael H Gewitz; David C Tong; James M Steckelberg; Robert S Baltimore; Stanford T Shulman; Jane C Burns; Donald A Falace; Jane W Newburger; Thomas J Pallasch; Masato Takahashi; Kathryn A Taubert
Journal:  Circulation       Date:  2005-06-14       Impact factor: 29.690

4.  Clinical features of patients with invasive Eikenella corrodens infections and microbiological characteristics of the causative isolates.

Authors:  W S Sheng; P R Hsueh; C C Hung; L J Teng; Y C Chen; K T Luh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-04       Impact factor: 3.267

Review 5.  Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.

Authors:  F Kate Gould; David W Denning; Tom S J Elliott; Juliet Foweraker; John D Perry; Bernard D Prendergast; Jonathan A T Sandoe; Michael J Spry; Richard W Watkin
Journal:  J Antimicrob Chemother       Date:  2011-11-14       Impact factor: 5.790

6.  Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Authors:  Gilbert Habib; Bruno Hoen; Pilar Tornos; Franck Thuny; Bernard Prendergast; Isidre Vilacosta; Philippe Moreillon; Manuel de Jesus Antunes; Ulf Thilen; John Lekakis; Maria Lengyel; Ludwig Müller; Christoph K Naber; Petros Nihoyannopoulos; Anton Moritz; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

7.  16S ribosomal DNA typing for identification of pathogens in patients with bacterial keratitis.

Authors:  C M Knox; V Cevellos; D Dean
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948
  7 in total
  8 in total

Review 1.  Infective endocarditis.

Authors:  Thomas L Holland; Larry M Baddour; Arnold S Bayer; Bruno Hoen; Jose M Miro; Vance G Fowler
Journal:  Nat Rev Dis Primers       Date:  2016-09-01       Impact factor: 52.329

2.  Clinical features and antimicrobial susceptibility of oral bacteria isolated from the blood cultures of patients with infective endocarditis.

Authors:  Keigo Maeda; Yuzo Hirai; Masanori Nashi; Shinsuke Yamamoto; Naoki Taniike; Toshihiko Takenobu
Journal:  J Dent Sci       Date:  2021-09-28       Impact factor: 3.719

3.  The first case of cholecytitis caused by Aggregatibacter kilianii in Korea.

Authors:  Dahae Yang; Chang-Ki Kim; Junja Park; Na Yeong Song; Yunna Lee; Woonhyoung Lee
Journal:  BMC Infect Dis       Date:  2022-05-26       Impact factor: 3.667

4.  Eikenella corrodens endocarditis and liver abscess in a previously healthy male, a case report.

Authors:  Anne Christine Nordholm; Ruth Ottilia Birgitta Vøgg; Henrik Permin; Terese Katzenstein
Journal:  BMC Infect Dis       Date:  2018-01-12       Impact factor: 3.090

5.  Role of granulocyte transfusions in combating life-threatening infections in patients with severe neutropenia: Experience from a tertiary care centre in North India.

Authors:  Akanksha Garg; Anshul Gupta; Ashish Mishra; Manoj Singh; Sanjeev Yadav; Soniya Nityanand
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

Review 6.  Current Evidence on Oral Antibiotics for Infective Endocarditis: A Narrative Review.

Authors:  Takaaki Kobayashi; Tomo Ando; Judy Streit; Poorani Sekar
Journal:  Cardiol Ther       Date:  2019-09-18

7.  An unusual case of multiple hepatic and pulmonary abscesses caused by Aggregatibacter aphrophilus in a young man: a case report.

Authors:  Johannes Sumer; Sabine Haller; Mikael Sawatzki; Jan Kellner; Katia Boggian
Journal:  J Med Case Rep       Date:  2021-02-04

Review 8.  Infective endocarditis by HACEK: a review.

Authors:  Mansoor Khaledi; Fatemeh Sameni; Hamed Afkhami; Jaber Hemmati; Aram Asareh Zadegan Dezfuli; Mohammad-Javad Sanae; Majid Validi
Journal:  J Cardiothorac Surg       Date:  2022-08-19       Impact factor: 1.522
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.